Noraina Muhamad Zakuan

Dr. Noraina Muhamad Zakuan


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2021 in Molecules
Verified
Journal Article
Open access
PDF file
NANurul Akmaryanti Abdullah
Nurul Akmaryanti Abdullah
NUR FARIESHA MD HASHIMNUR FARIESHA MD HASHIM
NUR FARIESHA MD HASHIM
AAAula Ammar
Aula Ammar
NZNoraina Muhamad Zakuan
Noraina Muhamad Zakuan
Cancer is one of the leading causes of death worldwide, with a mortality rate of more than 9 million deaths reported in 2018. Conventional anti-cancer therapy can greatly improve survival however treatment resistance is still a major problem especially in metastatic disease. Targeted anti-cancer therapy is increasingly used with conventional therapy to improve patients’ outcomes in advanced and metastatic tumors. However, due to the complexity of cancer biology and metastasis, it is urgent to develop new agents and evaluate the anti-cancer efficacy of available treatments. Many phytochemicals from medicinal plants have been reported to possess anti-cancer properties. One such compound is known as oridonin, a bioactive component of Rabdosia rubescens. Several studies have demonstrated that oridonin inhibits angiogenesis in various types of cancer, including breast, pancreatic, lung, colon and skin cancer. Oridonin’s anti-cancer effects are mediated through the modulation of several signaling pathways which include upregulation of oncogenes and pro-angiogenic growth factors. Furthermore, oridonin also inhibits cell migration, invasion and metastasis via suppressing epithelial-to-mesenchymal transition and blocking downstream signaling targets in the cancer metastasis process. This review summarizes the recent applications of oridonin as an anti-angiogenic and anti-metastatic drug both in vitro and in vivo, and its potential mechanisms of action.

26 August 2020 in Molecules
Verified
Journal Article
Open access
PDF file
HHHamad Ali Hamad
Hamad Ali Hamad
HEHamid Hammad Enezei
Hamid Hammad Enezei
AAAnmar Alrawas
Anmar Alrawas
NZNoraina Muhamad Zakuan
Noraina Muhamad Zakuan
NANurul Akmaryanti Abdullah
Nurul Akmaryanti Abdullah
NUR FARIESHA MD HASHIMNUR FARIESHA MD HASHIM
NUR FARIESHA MD HASHIM
Hypoxia plays a significant role in solid tumors by the increased expression of hypoxia-inducible factor-1α (HIF-1α), which is known to promote cancer invasion and metastasis. Cancer-cell invasion dynamically begins with the degradation of the extracellular matrix (ECM) via invadopodia formation. The chemical substrates that are utilized by hypoxic cells as fuel to drive invadopodia formation are still not fully understood. Therefore, the aim of the study was to maintain MDA-MB-231 cells under hypoxia conditions to allow cells to form a large number of invadopodia as a model, followed by identifying their nutrient utilization. The results of the study revealed an increase in the number of cells forming invadopodia under hypoxia conditions. Moreover, Western blot analysis confirmed that essential proteins for hypoxia and invadopodia, including HIF-1α, vascular endothelial growth factor (VEGF), metallopeptidase-2 (MMP-2), and Rho guanine nucleotide exchange factor 7 (β-PIX), significantly increased under hypoxia. Interestingly, phenotype microarray showed that only 11 chemical substrates from 367 types of substrates were significantly metabolized in hypoxia compared to in normoxia. This is thought to be fuel for hypoxia to drive the invasion process. In conclusion, we found 11 chemical substrates that could have potential energy sources for hypoxia-induced invadopodia formation of these cells. This may in part be a target in the hypoxic tumor and invadopodia formation. Additionally, these findings can be used as potential carrier targets in cancer-drug discovery, such as the usage of dextrin.

9 May 2024 in Life Sciences
Verified
Journal Article
Closed access
NANurul Akmaryanti Abdullah
Nurul Akmaryanti Abdullah
NHNur Fariesha Md Hashim
Nur Fariesha Md Hashim
NZNoraina Muhamad Zakuan
Noraina Muhamad Zakuan
JCJia Xin Chua
Jia Xin Chua

30 June 2020 in Sains Malaysiana
Verified
Journal Article
Closed access
MTMin Jien Tan
Min Jien Tan
SHSiti Nur Parvin Ab Hamid
Siti Nur Parvin Ab Hamid
NHNur Fariesha Md Hashim
Nur Fariesha Md Hashim
NANurdin Armania
Nurdin Armania
HSHasni Idayu Saidi
Hasni Idayu Saidi
NZNoraina Muhamad Zakuan
Noraina Muhamad Zakuan

30 June 2024 in Sains Malaysiana
Verified
Journal Article
Closed access
NANor Ezleen Qistina Ahmad
Nor Ezleen Qistina Ahmad
AYAmirah Alhusna Mohd Yusoff
Amirah Alhusna Mohd Yusoff
NHNur Fariesha Md Hashim
Nur Fariesha Md Hashim
NANurul Akmaryanti Abdullah
Nurul Akmaryanti Abdullah
NZNoraina Muhamad Zakuan
Noraina Muhamad Zakuan
Hypoxia, a condition characterised by low oxygen levels, leads to increased production of a protein called hypoxia-inducible factor-1 alpha (HIF-1α) in cancer cells. This protein is involved in driving processes such as vascularization, cytoskeletal reorganisation, and epithelial-to-mesenchymal transformation (EMT), which contribute to metastasis. Previous studies used hypoxic workstations, chambers, and incubators to evaluate the effects of hypoxia on colon cancer cell lines. In a cell culture model, hypoxic conditions can also be induced using dimethyloxalylglycine (DMOG) as the hypoxia-mimicking agent. This study aims to investigate the effects of DMOG-induced hypoxia on colon cancer metastasis, focusing on cell migration and invasion. HCT116 cells were subjected to hypoxic conditions by treating them with DMOG, and the expression of HIF-1α proteins was measured at various time points, followed by wound healing and invasion assays. It was found that HIF-1α protein expression increases after 6 h of DMOG induction and persists for 24 h. At 6 and 24 h, a significantly higher percentage of hypoxic cells migrated compared to normoxic cells. The invasion assay demonstrated that hypoxic cells were more invasive than normoxic cells within 24 h. Thus, the increase in migration and invasion of cells is comparable to the increase in HIF-1α expression at 6 and 24 h. These findings suggest that DMOG induces HIF-1α expression in colon cancer cells, leading to enhanced cell migration and invasiveness. The established model can be further utilised in gene knockdown or drug treatment studies to evaluate the effects of hypoxia on cancer cells.

13 May 2026 in Cytotechnology
Verified
Journal Article
Closed access
PDF file
NANurul Akmaryanti Abdullah
Nurul Akmaryanti Abdullah
AAAnis Hazirah Azman
Anis Hazirah Azman
QCQiao Yi Chong
Qiao Yi Chong
SSSharah Muhammad Shan
Sharah Muhammad Shan
NUR FARIESHA MD HASHIMNUR FARIESHA MD HASHIM
NUR FARIESHA MD HASHIM
NZNoraina Muhamad Zakuan
Noraina Muhamad Zakuan